Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Janssens

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2023
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trialAlexandra J Lansky, Bo Xu, Andreas Baumbach, et al.
Acta Cardiologica|November 30, 2017
Assessing the landscape of percutaneous coronary chronic total occlusion treatment in Belgium and Luxembourg: the Belgian Working Group on Chronic Total Occlusions (BWGCTO) registryJoren Maeremans, Peter Kayaert, Yoann Bataille, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III SubstudyKush P Patel, Alexandra J Lansky, Dean J Kereiakes, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
JACC. Cardiovascular Interventions|May 27, 2019
2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting StentBo Xu, Yuichi Saito, Andreas Baumbach, et al.
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Journal of the American College of Cardiology|November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary StentingAnna Franzone, Eugène McFadden, Sergio Leonardi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 11, 2017
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudyTaku Asano, Yuki Katagiri, Carlos Collet, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2023
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trialAlexandra J Lansky, Bo Xu, Andreas Baumbach, et al.
Acta Cardiologica|November 30, 2017
Assessing the landscape of percutaneous coronary chronic total occlusion treatment in Belgium and Luxembourg: the Belgian Working Group on Chronic Total Occlusions (BWGCTO) registryJoren Maeremans, Peter Kayaert, Yoann Bataille, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III SubstudyKush P Patel, Alexandra J Lansky, Dean J Kereiakes, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
JACC. Cardiovascular Interventions|May 27, 2019
2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting StentBo Xu, Yuichi Saito, Andreas Baumbach, et al.
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Journal of the American College of Cardiology|November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary StentingAnna Franzone, Eugène McFadden, Sergio Leonardi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 11, 2017
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudyTaku Asano, Yuki Katagiri, Carlos Collet, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
Pageof 12